More Yaz problems for Bayer. The FDA warned Bayer regarding quality control issues at a plant that makes the key ingredient in Yaz, a birth control drug that has generated 50 different lawsuits for issues unrelated to its manufacturing process.
The FDA said inspectors uncovered testing problems at Bayer’s manufacturing plant in Berghamen, Germany, during a March visit.FDA inspectors said the company measured the quality of its drug ingredients based on an average of several samples, instead of reporting individual tests results. Bayer shipped eight drug batches to the U.S. that were tested using this randomized method, which is not permissible under FDA regulations. The FDA’s message is simple: test them all.
Along with the overpromotion of Yaz, this is one more issue that – while arguably not relevant at trial in a DVT case – underscores the disaster that is Yaz/Yasmin.
Our Yaz lawyers are now investigating for potential lawsuits and, hopefully, future settlements of Yaz, Ocella and Yasmin claims, primarily for deep vein thrombosis and victims but also for others who have suffered gallbladder injuries, a heart attack or stroke while taking Yaz or Yasmin. Call 800-553-8082 to learn more about your potential Yaz claim.